Guillaume Pfefer, CEO of Senda Biosciences & »Æ¹ÏÊÓƵapp CEO-Partner, describes Senda’s work to unlock comprehensive programming of medicine and what is in store for the company in the year ahead. More from Flagship @ JPM2023 here.
More from:
Human Health

Pioneering Partnerships: Advancing a Portfolio of Novel Medicines and Vaccines with GSK

Pioneering Partnerships: Accelerating our Collaboration with Pfizer

Unlocking Therapeutic Breakthroughs with the Power of Platform Technologies

Halting the Trajectory of Disease with Preemptive Health

AI in Action
